RTX's $6.3B SM-3 Win Caps a $74B Missile Backlog Wave — And the Real Pricing Power Now Lives With the Sub-Tier Bottlenecks

The October 8, 2026 award of up to $6.3B to Raytheon for Standard Missile-3 Block IB interceptors is the latest in a sequence of multi-year U.S. missile production awards that, taken together, amount to roughly $74.1B of multi-year missile obligations in just over ten weeks. The contract — a five-year base deal at $4.4B with two option years worth up to another ~$2B, issued by the Missile Defense Agency — explicitly frames its purpose as breaking sub-tier manufacturing bottlenecks.

It is the smallest of the wave, but it sits on top of contracts that are already straining the defense industrial base: RTX's $22.9B seven-year Tomahawk award (Aug 17), RTX's $20.7B AMRAAM award targeting at least 1,900 missiles a year (Sep 28), Boeing's $14.7B seven-year PAC-3 MSE seeker award issued by Lockheed Martin (Oct 5–6), and RTX's $24.4B Standard Missile-6 award (Oct 1). Together these are multi-year obligations sized to roughly double or triple current interceptor and cruise-missile output.

RTX exited Q2 2026 with a record $289B total backlog, of which $119B is defense — up 22% year over year. Lockheed Martin reported a record $160B backlog. Northrop Grumman's backlog hit $104.7B at March 31, 2026. With the new awards, RTX defense backlog has grown materially since June. At these levels, prime production capacity is essentially sold out for years.

But the binding constraint has shifted. CSIS's June 12, 2026 report on solid rocket motors documents 25-to-51-month manufacturing lead times for critical weapons, persistent consolidation that left the U.S. with effectively one domestic supplier for advanced SRMs after decades of roll-ups, and PAC-3 MSE capacity plans that need to triple to 2,000 interceptors a year by 2030. The Pentagon's FY 2027 budget request targets a 188% increase in missile orders versus FY 2026 — multi-year contracts are the mechanism to make that level executable. Where the work actually happens is the question.

The clearest sign the bottleneck has moved is that the Department of War is no longer routing capacity investment exclusively through the primes. On January 13, 2026, the DoW announced a $1B direct-to-supplier convertible-preferred investment in L3Harris's Missile Solutions business (formerly Aerojet Rocketdyne, acquired in 2023), explicitly to expand solid rocket motor capacity for PAC-3, THAAD, Tomahawk, and Standard Missile — all four of the new RTX contracts. The transaction closed April 23, 2026. L3Harris had planned a H2 2026 IPO of Missile Solutions; it was pushed to mid-2027 in July because capacity expansion was the priority.

On March 24, 2026, the DoW and Honeywell Aerospace signed a supplier framework agreement under which the company committed $500M to expand production of precision-guided missile components, fuzing, and control electronics across more than 50 international programs. Honeywell Aerospace completed its spinoff from Honeywell International on June 29, 2026, and now trades as Honeywell Aerospace (HONA) — explicitly positioned as a tier-one missile-component supplier into the ramp. Mercury Systems ended FY2026 (July 3, 2026) with a record $1.9B backlog, up ~$540M year-over-year, on Q4 bookings of $660M and a 2.28 book-to-bill.

Kratos is the wildest expression of the same dynamic. Q2 2026 organic revenue grew 30.5%, consolidated backlog reached $2.08B, and the company broke ground on the Prometheus solid rocket motor campus — production starts 2027 with $175M committed. RTX's Q2 2026 release credits its AMRAAM ramp partly to \"hundreds of small and mid-sized suppliers,\" and explicitly notes that even RTX's AMRAAM production was nearly doubled in 2025 versus 2024 — implying the sub-tier base is already absorbing major incremental orders.

Raytheon's Q2 2026 segment told the prime-side story clearly: sales of $8,269M were up 18% year-over-year, operating profit of $1,042M was up 29% — operating margin expanded to roughly 12.6% from 11.5% a year earlier, on volume growth in land and air defense, naval programs, and air-and-space defense systems (Patriot, Standard Missile, AMRAAM). The marginal economics look better than the average backlog, consistent with pricing power on constrained capacity.

On valuation: RTX trades at ~32× trailing earnings on $93.5B TTM revenue and a $248B market cap, with $289B backlog and $119B defense backlog already on the books. Lockheed Martin trades at ~18.4× earnings on $77B TTM revenue with a $160B backlog. Northrop Grumman trades at ~15.4× earnings on $42.9B TTM revenue and a $104.7B backlog. None of the primes is cheap on absolute multiple — but each is converting the same bottleneck into margin upside.

On the supplier side, the same margin math applies at smaller scale. L3Harris's Missile Solutions now carries the DoW's $1B preferred-equity investment and is the named SRM supplier for every major RTX award above — the spinout values a public-market read on the rent. Honeywell Aerospace just spun off with a $500M DoW-aligned capex commitment and an explicit tier-one missile-component mandate. Kratos' 30.5% Q2 organic growth and a doubling backlog in twelve months show what a sub-tier node looks like when the bottleneck snaps to it. Mercury Systems is the named RF/microwave bottleneck node on missile seekers and EW subsystems.

The cleanest synthesis: capacity — not demand — has been the binding constraint on U.S. missile production for at least three years. The five multi-year contracts above explicitly price in the cost of unlocking sub-tier supply. Primes win because their pricing power is now structurally higher on captive capacity; sub-tier suppliers win because the Pentagon is routing capital directly to them. The two outcomes reinforce each other. The under-priced leg of the trade, by both magnitude and persistence, is the sub-tier rent capture.